See analyst estimates and all valuation multiples for Nutraceuticals & Cosmeceuticals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $23.1B | 1.4x | 6.2x | |
| $20.7B | 18.0x | 55.5x | |
| $16.6B | 10.7x | 31.5x | |
| $9.4B | 2.9x | 7.2x | |
| $8.1B | 10.7x | 39.5x | |
| $6.6B | 4.3x | 21.9x | |
| $4.1B | 2.0x | 13.0x | |
| $4.1B | 12.6x | 30.3x | |
| $3.5B | n/a | n/a | |
| $3.2B | 2.3x | 8.5x | |
| $3.1B | 1.4x | 8.4x | |
| $2.5B | 8.2x | 16.1x | |
| $1.6B | 6.5x | 24.9x | |
| $1.5B | n/a | n/a | |
| $1.3B | 2.2x | 11.3x | |
| $1.1B | 7.9x | 27.8x | |
| $1.1B | 0.9x | 3.9x | |
| $1.1B | n/a | n/a | |
| $1.0B | n/a | n/a | |
| $1.0B | 6.6x | 19.9x | |
| $863M | 3.5x | 9.1x | |
| $708M | n/a | n/a | |
| $648M | 1.4x | 6.8x | |
| $583M | 11.2x | 31.2x | |
| $511M | 3.5x | 13.2x | |
| $507M | n/a | n/a | |
| $223M | 3.2x | n/a | |
| $131M | 2.0x | 9.1x | |
| $94.0M | n/a | n/a | |
| $33.2M | n/a | n/a | |
| $23.1M | n/a | n/a | |
| $20.9M | 0.8x | -30.5x | |
| $18.2M | 14.8x | -1.6x | |
| $14.5M | n/a | n/a | |
| $8.1M | n/a | n/a | |
| $4.3M | n/a | n/a | |
| $3.3M | n/a | n/a | |
| -$3.2M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Nutraceuticals & Cosmeceuticals